Cardiac Uptake of Minocycline and Mechanisms for In Vivo Cardioprotection
- 1 September 2008
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 52 (13) , 1086-1094
- https://doi.org/10.1016/j.jacc.2008.06.028
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Inhibition of matrix metalloproteinases prevents peroxynitrite‐induced contractile dysfunction in the isolated cardiac myocyteBritish Journal of Pharmacology, 2008
- Characterization of Minocycline Transport by Human NeutrophilsThe Journal of Periodontology, 2006
- Dose–Response Effect of Tetracyclines on Cerebral Matrix Metalloproteinase-9 after Vascular Endothelial Growth Factor HyperstimulationJournal of Cerebral Blood Flow & Metabolism, 2006
- Tetracyclines: Nonantibiotic properties and their clinical implicationsJournal of the American Academy of Dermatology, 2006
- Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical‐scavenging activityJournal of Neurochemistry, 2005
- Molecular Interactions between Matrilysin and the Matrix Metalloproteinase Inhibitor Doxycycline Investigated by Deuterium Exchange Mass SpectrometryMolecular Pharmacology, 2005
- Abnormal cardiac wall motion and early matrix metalloproteinase activityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Early Short-Term Treatment With Doxycycline Modulates Postinfarction Left Ventricular RemodelingCirculation, 2003
- S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell DeathScience, 2002
- Tetracycline and Its Derivatives Strongly Bind to and Are Released From the Tooth Surface in Active FormThe Journal of Periodontology, 1983